Proposed drug-drug cost effectiveness methodology.

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Clinical Pharmacy

Background:

• Prospective reimbursement models necessitate rigorous evaluation of drug cost-effectiveness.
• Hospital administrators and formulary committees face challenges in comparing similar drugs.
• Existing literature on drug-drug cost-effectiveness procedures requires synthesis and practical application.

Purpose of the Study:

• To review existing literature on drug-drug cost-effectiveness procedures.
• To outline a practical methodology for comparing the cost-effectiveness of two drugs with similar therapeutic outcomes.
• To discuss the implications of cost-effectiveness analysis for hospital formulary decision-making.

Main Methods:

• Literature review of drug-drug cost-effectiveness procedures.
• Development of a methodology for comparative drug evaluation.
• Utilizing data from clinical studies and company sources.
• Employing microcomputer electronic spreadsheets for data analysis.

Main Results:

• A structured methodology for comparing cost-effectiveness of similar drugs is presented.
• The analysis framework facilitates data integration from diverse sources.
• The approach provides a basis for informed decisions by pharmacy and therapeutic committees.

Conclusions:

• Cost-effectiveness analysis is a crucial tool for hospital formulary committees.
• The proposed methodology offers a systematic approach to drug evaluation under prospective reimbursement.
• Effective drug evaluation supports optimal resource allocation and patient care.